Cite
HARVARD Citation
Khlyabova, P. et al. (n.d.). SAT0040 Safety, tolerability, pharmacokinetics and pharmacodynamics of bcd-089, novel monoclonal anti-il-6 receptor antibody: results from the first-in-human single dose escalation study in healthy volunteers. Annals of the rheumatic diseases. pp. 884-885. [Online].